Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque-type Psoriasis”

170 trials

Showing 20 of 170 results

Testing effectiveness (Phase 2)Study completedNCT02295865
What this trial is testing

Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 62
Large-scale testing (Phase 3)Study completedNCT02581345
What this trial is testing

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque PsoriasisPsoriasis
Momenta Pharmaceuticals, Inc. 572
Large-scale testing (Phase 3)UnknownNCT01628081
What this trial is testing

The Effect of Alga Dunaliella Bardawil on Psoriasis

Who this might be right for
Psoriasis
Sheba Medical Center 46
Early research (Phase 1)Study completedNCT01582932
What this trial is testing

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 36
Early research (Phase 1)Study completedNCT00762658
What this trial is testing

A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test

Who this might be right for
Psoriasis
Pfizer 12
Large-scale testing (Phase 3)Study completedNCT03818035
What this trial is testing

Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag International NV 880
Testing effectiveness (Phase 2)Study completedNCT04629950
What this trial is testing

Rimegepant in Moderate Plaque-type Psoriasis

Who this might be right for
Psoriasis
Weill Medical College of Cornell University 41
Early research (Phase 1)Study completedNCT01646567
What this trial is testing

SHP-141C in Plaque Type Psoriasis

Who this might be right for
Plaque Type Psoriasis
TetraLogic Pharmaceuticals 14
Not applicableStudy completedNCT00098189
What this trial is testing

Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Novartis
Not applicableStudy completedNCT01320293
What this trial is testing

Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

Who this might be right for
Psoriasis
University of North Carolina, Chapel Hill 18
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Post-approval studies (Phase 4)Ended earlyNCT00924950
What this trial is testing

Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasis Vulgaris
University of California, San Francisco 35
Testing effectiveness (Phase 2)Study completedNCT03553823
What this trial is testing

Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT00606450
What this trial is testing

Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Amgen 260
Large-scale testing (Phase 3)Study completedNCT01321164
What this trial is testing

Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis

Who this might be right for
Plaque Psoriasis
Medical University of Vienna 30
Early research (Phase 1)Study completedNCT03724292
What this trial is testing

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers

Who this might be right for
Psoriasis
Vitae Pharmaceuticals Inc., an Allergan affiliate 40
Large-scale testing (Phase 3)Study completedNCT02203032
What this trial is testing

Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 872
Testing effectiveness (Phase 2)Study completedNCT02173301
What this trial is testing

Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Dr. Reddy's Laboratories Limited 200
Not applicableUnknownNCT01339741
What this trial is testing

Efficacy of Vitamin D3 for the Treatment of Psoriatic Patients With Vitamin D Deficiency and Insufficiency

Who this might be right for
Psoriasis VulgarisVitamin D Deficiency
Chulalongkorn University 30
Large-scale testing (Phase 3)Study completedNCT01177800
What this trial is testing

Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Xian-Janssen Pharmaceutical Ltd. 129
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation